CAMBRIDGE, Mass., April 30, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc., (Nasdaq:IDIX) announced today that Idenix management will present a corporate overview at the Deutsche Bank 37th Annual Healthcare Conference on May 7, 2012 at 3:30 p.m. EDT at the Intercontinental Hotel, Boston and at the Bank of America Merrill Lynch Global Health Care Conference on May 15, 2012 at 1:40 p.m. PDT at the Wynn Encore, Las Vegas.
The live and archived webcasts of the company presentations can be accessed under "Calendar of Events" in the Idenix Investor Center at www.idenix.com. Please log in approximately 5-10 minutes before each event to ensure a timely connection. The archived replay will be available on the Idenix website for two weeks following the conferences.
About Idenix
Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix's current focus is on the treatment of patients with chronic hepatitis C infection. For further information about Idenix, please refer to http://www.idenix.com.